Literature DB >> 2564060

Molecular genetics of amyloid neuropathy in Europe.

I J Holt1, A E Harding, L Middleton, G Chrysostomou, G Said, R H King, P K Thomas.   

Abstract

The Portuguese type of familial amyloid polyneuropathy (FAP type I), a disabling autosomal dominant disorder with onset in early adult life, is caused by a point mutation in the transthyretin (TTR; previously known as prealbumin) gene. DNA analysis in thirteen European families (one British, two French, one Italian, one Greek, and eight Cypriot) showed that members of all those from Cyprus and Greece, and one from France, carried the FAP type I mutation. Patients from seven of these ten kindreds were not known to have a genetic disease before this study, which demonstrated the mutation in 16 of 43 clinically unaffected relatives. 2 of these were aged over 50 years. TTR gene analysis has useful applications in genetic counselling, including prenatal diagnosis, in identifying the cause of seemingly sporadic cases of amyloid neuropathy, and in epidemiological studies of FAP.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2564060     DOI: 10.1016/s0140-6736(89)90068-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  8 in total

1.  Ultrastructural immunolabelling of amyloid fibrils in acquired and hereditary amyloid neuropathies.

Authors:  D Adams; G Said
Journal:  J Neurol       Date:  1996-01       Impact factor: 4.849

2.  Haemarthrosis due to fracture through amyloid deposits in bone in Portuguese familial amyloidosis.

Authors:  S A Allard; R H King; P K Thomas; B E Bourke
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

3.  Type I familial amyloid polyneuropathy and pontine haemorrhage.

Authors:  J Arpa Gutiérrez; C Morales; M Lara; C Muñoz; M García-Rojo; A Caminero; M Gutiérrez
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

4.  Haplotype analysis of French, British and other European patients with familial amyloid polyneuropathy (met 30 and tyr 77).

Authors:  M M Reilly; D Adams; M B Davis; G Said; A E Harding
Journal:  J Neurol       Date:  1995-10       Impact factor: 4.849

5.  Impact of familial amyloid associated polyneuropathy on duodenal endocrine cells.

Authors:  M el-Salhy; O Suhr; R Stenling; E Wilander; L Grimelius
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

6.  Transthyretin gene mutations in British and French patients with amyloid neuropathy.

Authors:  K Bhatia; M Reilly; D Adams; M B Davis; C H Hawkes; P K Thomas; G Said; A E Harding
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-06       Impact factor: 10.154

7.  Tau-mediated nuclear depletion and cytoplasmic accumulation of SFPQ in Alzheimer's and Pick's disease.

Authors:  Yazi D Ke; Yazi Ke; Joe Dramiga; Ulrich Schütz; Jillian J Kril; Lars M Ittner; Hannsjörg Schröder; Jürgen Götz
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

Review 8.  Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP.

Authors:  Yesim Parman; David Adams; Laura Obici; Lucía Galán; Velina Guergueltcheva; Ole B Suhr; Teresa Coelho
Journal:  Curr Opin Neurol       Date:  2016-02       Impact factor: 5.710

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.